No­var­tis chief says Trump visa re­stric­tions sour US hir­ing plans; Parex­el and Sanofi to de­vel­op wear­able de­vices

→  Don’t look for No­var­tis CEO Joe Jimenez to add many new jobs in the US any­time soon. In re­cent in­ter­views the phar­ma chief says that new visa re­stric­tions ad­vanced by the Trump ad­min­is­tra­tion has soured his ap­petite for any ex­pan­sion in the US. The com­pa­ny has al­ready felt the ef­fects on hir­ing for­eign na­tion­als. “This makes the coun­try a less at­trac­tive lo­ca­tion for in­vest­ment…by con­trast, Switzer­land and Eu­rope will be­come more at­trac­tive,” he said. Jimenez was one of sev­er­al in­dus­try lead­ers to meet with the pres­i­dent in Jan­u­ary about de­creas­ing drug prices and in­creas­ing jobs in the Unit­ed States.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.